Journal Article

Bundred, N. J., Morrison, J. M., Ratcliffe, W. A., Ratcliffe, J. G., Warwick, Jane and Walker, R. A. (1992) Parathyroid hormone related protein and skeletal morbidity in breast cancer. European Journal of Cancer Care, Volume 28 (Number 2-3). pp. 690-692. doi:10.1016/S0959-8049(05)80127-3 ISSN 0961-5423.

Finn, C. B., Luesley, D. M., Buxton, E. J., Blackledge, G. R., Kelly, K., Dunn, Janet A. and Wilson, S. (1992) Is stage I epithelial ovarian cancer over-treated both surgically and systematically? Results of a five-year cancer registry review. Obstetrical and Gynecological Survey, 47 (7). pp. 491-493. doi:10.1016/0197-2456(92)90198-9 ISSN 0029-7828.

Finn, Catherine B., Luesley, D. M., Buxton, E. J., Blackledge, G. R., Kelly, K., Dunn, Janet A. and Wilson, S. (1992) Is Stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five-year cancer registry review. BJOG: An International Journal of Obstetrics and Gynaecology, 99 (1). pp. 54-58. doi:10.1111/j.1471-0528.1992.tb14393.x ISSN 1470-0328.

Lynch, T. H., Waymont, B., Dunn, Janet A. and Wallace, D. M. A. (1992) Urologists' attitudes to the management of bladder cancer. British Journal of Urology, 70 (5). pp. 522-525. doi:10.1111/bju.1992.70.5.522 ISSN 0007-1331.

The Medical Research Council Working Party For Leukæmia In Adults (Including: MacLennan, I. C. M., Chapman, C., Dunn, Janet A. and Kelly, K.). (1992) Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis. The Lancet, 339 (8787). pp. 200-205. doi:10.1016/0140-6736(92)90004-M ISSN 0140-6736.

Oláh, K. S., Dunn, Janet A. and Gee, H. (1992) Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors : the result of a retrospective study of 423 cases of uterine sarcoma. BJOG: An International Journal of Obstetrics & Gynaecology, 99 (7). pp. 590-594. doi:10.1111/j.1471-0528.1992.tb13827.x ISSN 1470-0328.

Ward, L. C., Fielding, J. W. L. and Dunn, Janet A. (1992) The selection of cases for randomised trials : a registry survey of concurrent trial and non-trial patients. British Journal of Cancer, 66 (5). pp. 943-950. doi:10.1038/bjc.1992.390 ISSN 0007-0920.

Waymont, B., Lynch, T. H., Dunn, Janet A., Emtage, L. A., Arkell, D. G., Wallace, D. M. A. and Blackledge, G. R. P. (1992) Phase III randomised study of Zoladex versus Stilboestrol in the treatment of advanced prostate cancer. British Journal of Urology, 69 (6). pp. 614-620. doi:10.1111/j.1464-410X.1992.tb15633.x ISSN 0007-1331.

Journal Item

Clarke, M., Gray, R., Dunn, Janet A. and Maclennan, I. (1992) Combination chemotherapy for myelomatosis. The Lancet, 340 (8816). p. 433. doi:10.1016/0140-6736(92)91520-I

Dunn, Janet A. (1992) Prognostic indices : who needs them? Controlled Clinical Trials, 13 (5). pp. 381-382. doi:10.1016/0197-2456(92)90053-3

Dunn, Janet A. and Hallissey, M. T. (1992) Developing a prognostic index for stomach cancer. Controlled Clinical Trials, 13 (5). p. 427. doi:10.1016/0197-2456(92)90163-T

Dunn, Janet A. and MacLennan, I. (1992) Comparing trials for the treatment of myelomatosis. Controlled Clinical Trials, 13 (5). p. 441. doi:10.1016/0197-2456(92)90198-9